相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation
Tetsuya Tajima et al.
LIVER TRANSPLANTATION (2023)
The impact of preformed donor-specific antibodies in living donor liver transplantation according to graft volume
Ryoichi Goto et al.
IMMUNITY INFLAMMATION AND DISEASE (2022)
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution
Roberta Angelico et al.
LIVER TRANSPLANTATION (2022)
Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management
Sandy Feng et al.
HEPATOLOGY (2021)
Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy
Dominique Schluckebier et al.
PEDIATRIC TRANSPLANTATION (2020)
Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients
Vladimir L. Cousin et al.
TRANSPLANTATION (2020)
Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients
Myriam Dao et al.
LIVER TRANSPLANTATION (2018)
HLA Diagnostics: Evaluating DSA Strength by Titration
Anat R. Tambur et al.
TRANSPLANTATION (2018)
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants
Sandy Feng et al.
GASTROENTEROLOGY (2018)
Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation
Eduardo Couchonnal et al.
TRANSPLANT IMMUNOLOGY (2017)
Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score's Ability to Determine Long-term Outcome
Jacqueline G. O'Leary et al.
TRANSPLANTATION (2017)
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group
James M. Neuberger et al.
TRANSPLANTATION (2017)
Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients
J. Levitsky et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'
Peter T. W. Kim et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2016)
A Pilot Study of Operational Tolerance With a Regulatory T-cell-Based Cell Therapy in Living Donor Liver Transplantation
Satoru Todo et al.
HEPATOLOGY (2016)
Donor-specific antibodies and liver transplantation
Arnaud Del Bello et al.
HUMAN IMMUNOLOGY (2016)
The Significance of Screening for HLA Antibodies in the Long-Term Follow-up of Pediatric Liver Transplant Recipients
K. Tokodai et al.
TRANSPLANTATION PROCEEDINGS (2016)
Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients
S. Varma et al.
EBIOMEDICINE (2016)
Donor age and operational tolerance in living donor liver transplantation
Yukihiro Sanada et al.
PEDIATRIC TRANSPLANTATION (2015)
Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
Jorge Malheiro et al.
TRANSPLANT IMMUNOLOGY (2015)
Application of Complement Component 4d Immunohistochemistry to ABO-Compatible and ABO-Incompatible Liver Transplantation
Adeeb Salah et al.
LIVER TRANSPLANTATION (2014)
Donor-Specific Alloantibodies Are Associated With Fibrosis Progression After Liver Transplantation in Hepatitis C Virus-Infected Patients
Jacqueline G. O'Leary et al.
LIVER TRANSPLANTATION (2014)
De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients
H. Kaneku et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Ischemia-Reperfusion Injury Accelerates Human Antibody-Mediated Transplant Vasculopathy
Ryoichi Goto et al.
TRANSPLANTATION (2013)
The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes
Maria Cecilia S. Freitas et al.
TRANSPLANTATION (2013)
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Prevalence, Course and Impact of HLA Donor-Specific Antibodies in Liver Transplantation in the First Year
T. Taner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal
Hiroto Egawa et al.
HEPATOLOGY RESEARCH (2012)
Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation
Jennifer M. DeVos et al.
KIDNEY INTERNATIONAL (2012)
Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts
Aya Miyagawa-Hayashino et al.
LIVER TRANSPLANTATION (2012)
Detection and clinical relevance of donor specific HLA antibodies: a matter of debate
Dave L. Roelen et al.
TRANSPLANT INTERNATIONAL (2012)
High Mean Fluorescence Intensity Donor-Specific Anti-HLA Antibodies Associated With Chronic Rejection Postliver Transplant
J. G. O'Leary et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study
Q. Mao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival
P. I. Terasaki et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
分享论文
